It takes two to tango: Protein-protein interactions in the translocation of pathogens across a blood-brain barrier

The Blood-Brain Barrier: New Research

Volumn , Issue , 2012, Pages 79-116

  Pulzova, L ^a,b   Mlynarcik, P ^a   Bencurova, E ^a   Bhide, M ^a,b  

^a UNIVERSITY OF VETERINARY MEDICINE   (Slovakia)

^b INSTITUTE OF NEUROIMMUNOLOGY   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892583342     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (212)

1. Kim, K.S., Mechanisms of microbial traversal of the blood-brain barrier. Nat Rev Microbiol, 2008. 6(8): p. 625-34.
2. MacIntyre, A., et al., Chlamydia pneumoniae infection alters the junctional complex proteins of human brain microvascular endothelial cells. FEMS Microbiol Lett, 2002. 217(2): p. 167-72.
3. Batinac, T., et al., Lyme borreliosis and multiple sclerosis are associated with primary effusion lymphoma. Med Hypotheses, 2007. 69(1): p. 117-9.
4. Miklossy, J., et al., Borrelia burgdorferi persists in the brain in chronic lyme neuroborreliosis and may be associated with Alzheimer's disease. J Alzheimers Dis, 2004. 6(6): p. 639-49; discussion 673-81.
5. Pardridge, W.M., Receptor-mediated peptide transport through the blood-brain barrier. Endocr Rev, 1986. 7(3): p. 314-30.
6. Reese, T.S. and M.J. Karnovsky, Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol, 1967. 34(1): p. 207-17.
7. Archer, D.P. and P.A. Ravussin, [Role of blood-brain barrier in cerebral homeostasis]. Ann Fr Anesth Reanim, 1994. 13(1): p. 57-61.
8. Hafler, D.A. and H.L. Weiner, T cells in multiple sclerosis and inflammatory central nervous system diseases. Immunol Rev, 1987. 100: p. 307-32.
9. Carson, M.J., et al., CNS immune privilege: hiding in plain sight. Immunol Rev, 2006. 213: p. 48-65.
10. Lightman, S.L., et al., Quantitative assessment of the permeability of the rat blood-retinal barrier to small water-soluble non-electrolytes. J Physiol, 1987. 389: p. 483-90.
11. Huber, J.D., R.D. Egleton, and T.P. Davis, Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci, 2001. 24(12): p. 719-25.
12. Tsukita, S., M. Furuse, and M. Itoh, Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol, 2001. 2(4): p. 285-93.
13. Tang, V.W. and D.A. Goodenough, Paracellular ion channel at the tight junction. Biophys J, 2003. 84(3): p. 1660-73.
14. Lu, L., et al., Comparative proteome analysis of rat brain and coronary microvascular endothelial cells. Physiol Res, 2007. 56(2): p. 159-68.
15. Nagasawa, K., et al., Possible involvement of gap junctions in the barrier function of tight junctions of brain and lung endothelial cells. J Cell Physiol, 2006. 208(1): p. 123-32.
16. Stevens, T., et al., NHLBI workshop report: endothelial cell phenotypes in heart, lung, and blood diseases. Am J Physiol Cell Physiol, 2001. 281(5): p. C1422-33.
17. Hirase, T., et al., Occludin as a possible determinant of tight junction permeability in endothelial cells. J Cell Sci, 1997. 110 (Pt 14): p. 1603-13.
18. Shusta, E.V., et al., Subtractive expression cloning reveals high expression of CD46 at the blood-brain barrier. J Neuropathol Exp Neurol, 2002. 61(7): p. 597-604.
19. Shusta, E.V., et al., The Ro52/SS-A autoantigen has elevated expression at the brain microvasculature. Neuroreport, 2003. 14(14): p. 1861-5.
20. Grab, D.J., et al., Borrelia burgdorferi, host-derived proteases, and the blood-brain barrier. Infect Immun, 2005. 73(2): p. 1014-22.
21. Hawkins, B.T. and T.P. Davis, The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev, 2005. 57(2): p. 173-85.
22. Juhler, M., et al., A spatial analysis of the blood-brain barrier damage in experimental allergic encephalomyelitis. J Cereb Blood Flow Metab, 1985. 5(4): p. 545-53.
23. Kim, K.S., Microbial translocation of the blood-brain barrier. Int J Parasitol, 2006. 36(5): p. 607-14.
24. Liu, N.Q., et al., Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway. J Virol, 2002. 76(13): p. 6689-700.
25. Drevets, D.A., et al., The Ly-6Chigh monocyte subpopulation transports Listeria monocytogenes into the brain during systemic infection of mice. J Immunol, 2004. 172(7): p. 4418-24.
26. Nguyen, L. and J. Pieters, The Trojan horse: survival tactics of pathogenic mycobacteria in macrophages. Trends Cell Biol, 2005. 15(5): p. 269-76.
27. Toborek, M., et al., Mechanisms of the blood-brain barrier disruption in HIV-1 infection. Cell Mol Neurobiol, 2005. 25(1): p. 181-99.
28. Khan, N.A., Acanthamoeba invasion of the central nervous system. Int J Parasitol, 2007. 37(2): p. 131-8.
29. Chang, Y.C., et al., Cryptococcal yeast cells invade the central nervous system via transcellular penetration of the blood-brain barrier. Infect Immun, 2004. 72(9): p. 4985-95.
30. Charlier, C., et al., Capsule structure changes associated with Cryptococcus neoformans crossing of the blood-brain barrier. Am J Pathol, 2005. 166(2): p. 421-32.
31. Comstock, L.E. and D.D. Thomas, Characterization of Borrelia burgdorferi invasion of cultured endothelial cells. Microb Pathog, 1991. 10(2): p. 137-48.
32. Comstock, L.E. and D.D. Thomas, Penetration of endothelial cell monolayers by Borrelia burgdorferi. Infect Immun, 1989. 57(5): p. 1626-8.
33. Zhang, J.R. and E. Tuomanen, Molecular and cellular mechanisms for microbial entry into the CNS. J Neurovirol, 1999. 5(6): p. 591-603.
34. Huang, S.H., M.F. Stins, and K.S. Kim, Bacterial penetration across the blood-brain barrier during the development of neonatal meningitis. Microbes Infect, 2000. 2(10): p. 1237-44.
35. Lossinsky, A.S. and R.R. Shivers, Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review. Histol Histopathol, 2004. 19(2): p. 535-64.
36. Yoshida, M., et al., Leukocyte adhesion to vascular endothelium induces E-selectin linkage to the actin cytoskeleton. J Cell Biol, 1996. 133(2): p. 445-55.
37. Kim, K.S., Strategy of Escherichia coli for crossing the blood-brain barrier. J Infect Dis, 2002. 186 Suppl 2: p. S220-4.
38. Nizet, V., et al., Invasion of brain microvascular endothelial cells by group B streptococci. Infect Immun, 1997. 65(12): p. 5074-81.
39. Nizet, V., R.L. Gibson, and C.E. Rubens, The role of group B streptococci beta-hemolysin expression in newborn lung injury. Adv Exp Med Biol, 1997. 418: p. 627-30.
40. Ring, A., J.N. Weiser, and E.I. Tuomanen, Pneumococcal trafficking across the blood-brain barrier. Molecular analysis of a novel bidirectional pathway. J Clin Invest, 1998. 102(2): p. 347-60.
41. Greiffenberg, L., et al., Interaction of Listeria monocytogenes with human brain microvascular endothelial cells: InlB-dependent invasion, long-term intracellular growth, and spread from macrophages to endothelial cells. Infect Immun, 1998. 66(11): p. 5260-7.
42. Jain, S.K., et al., Mycobacterium tuberculosis invasion and traversal across an in vitro human blood-brain barrier as a pathogenic mechanism for central nervous system tuberculosis. J Infect Dis, 2006. 193(9): p. 1287-95.
43. Thomas, D.D. and L.M. Higbie, In vitro association of leptospires with host cells. Infect Immun, 1990. 58(3): p. 581-5.
44. Jong, A.Y., et al., Traversal of Candida albicans across human blood-brain barrier in vitro. Infect Immun, 2001. 69(7): p. 4536-44.
45. Verma, S., et al., West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: Transmigration across the in vitro blood-brain barrier. Virology, 2009. 385(2): p. 425-433.
46. Tuomanen, E., Entry of pathogens into the central nervous system. FEMS Microbiol Rev, 1996. 18(4): p. 289-99.
47. Grab, D.J., et al., African trypanosome interactions with an in vitro model of the human blood-brain barrier. J Parasitol, 2004. 90(5): p. 970-9.
48. Haake, D.A. and M.A. Lovett, Interjunctional invasion of endothelial cell monolayers. Methods Enzymol, 1994. 236: p. 447-63.
49. Galan, J.E. and D. Zhou, Striking a balance: modulation of the actin cytoskeleton by Salmonella. Proc Natl Acad Sci U S A, 2000. 97(16): p. 8754-61.
50. Masuda, M., et al., Activation of rho through a cross-link with polyamines catalyzed by Bordetella dermonecrotizing toxin. EMBO J, 2000. 19(4): p. 521-30.
51. Chen, Y.H., et al., Enhanced Escherichia coli invasion of human brain microvascular endothelial cells is associated with alternations in cytoskeleton induced by nicotine. Cell Microbiol, 2002. 4(8): p. 503-14.
52. Eugene, E., et al., Microvilli-like structures are associated with the internalization of virulent capsulated Neisseria meningitidis into vascular endothelial cells. J Cell Sci, 2002. 115(Pt 6): p. 1231-41.
53. Abbott, N.J., Inflammatory mediators and modulation of blood-brain barrier permeability. Cell Mol Neurobiol, 2000. 20(2): p. 131-47.
54. Bazzoni, G., Endothelial tight junctions: permeable barriers of the vessel wall. Thromb Haemost, 2006. 95(1): p. 36-42.
55. Ferrieri, P., B. Burke, and J. Nelson, Production of bacteremia and meningitis in infant rats with group B streptococcal serotypes. Infect Immun, 1980. 27(3): p. 1023-32.
56. Hoffman, J.A., et al., Escherichia coli K1 aslA contributes to invasion of brain microvascular endothelial cells in vitro and in vivo. Infect Immun, 2000. 68(9): p. 5062-7.
57. Xie, Y., K.J. Kim, and K.S. Kim, Current concepts on Escherichia coli K1 translocation of the blood-brain barrier. FEMS Immunol Med Microbiol, 2004. 42(3): p. 271-9.
58. Wang, Y., et al., The gene locus yijP contributes to Escherichia coli K1 invasion of brain microvascular endothelial cells. Infect Immun, 1999. 67(9): p. 4751-6.
59. Wang, Y. and K.S. Kim, Role of OmpA and IbeB in Escherichia coli K1 invasion of brain microvascular endothelial cells in vitro and in vivo. Pediatr Res, 2002. 51(5): p. 559-63.
60. Khan, N.A., et al., FimH-mediated Escherichia coli K1 invasion of human brain microvascular endothelial cells. Cell Microbiol, 2007. 9(1): p. 169-78.
61. Khan, N.A., et al., Cytotoxic necrotizing factor-1 contributes to Escherichia coli K1 invasion of the central nervous system. J Biol Chem, 2002. 277(18): p. 15607-12.
62. Chung, J.W., et al., 37-kDa laminin receptor precursor modulates cytotoxic necrotizing factor 1-mediated RhoA activation and bacterial uptake. J Biol Chem, 2003. 278(19): p. 16857-62.
63. Tenenbaum, T., et al., Adherence to and invasion of human brain microvascular endothelial cells are promoted by fibrinogen-binding protein FbsA of Streptococcus agalactiae. Infect Immun, 2005. 73(7): p. 4404-9.
64. Maisey, H.C., et al., Group B streptococcal pilus proteins contribute to adherence to and invasion of brain microvascular endothelial cells. J Bacteriol, 2007. 189(4): p. 1464-7.
65. Tenenbaum, T., et al., Streptococcus agalactiae invasion of human brain microvascular endothelial cells is promoted by the laminin-binding protein Lmb. Microbes Infect, 2007. 9(6): p. 714-20.
66. Doran, K.S., G.Y. Liu, and V. Nizet, Group B streptococcal beta-hemolysin/cytolysin activates neutrophil signaling pathways in brain endothelium and contributes to development of meningitis. J Clin Invest, 2003. 112(5): p. 736-44.
67. van Sorge, N.M., et al., The group B streptococcal serine-rich repeat 1 glycoprotein mediates penetration of the blood-brain barrier. J Infect Dis, 2009. 199(10): p. 1479-87.
68. Doran, K.S., et al., Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. J Clin Invest, 2005. 115(9): p. 2499-507.
69. Kim, K.J., J.W. Chung, and K.S. Kim, 67-kDa laminin receptor promotes internalization of cytotoxic necrotizing factor 1-expressing Escherichia coli K1 into human brain microvascular endothelial cells. J Biol Chem, 2005. 280(2): p. 1360-8.
70. Maisey, H.C., K.S. Doran, and V. Nizet, Recent advances in understanding the molecular basis of group B Streptococcus virulence. Expert Rev Mol Med, 2008. 10: p. e27.
71. Seifert, K.N., et al., Characterization of group B streptococcal glyceraldehyde-3-phosphate dehydrogenase: surface localization, enzymatic activity, and protein-protein interactions. Can J Microbiol, 2003. 49(5): p. 350-6.
72. Kim, K.S., Pathogenesis of bacterial meningitis: from bacteraemia to neuronal injury. Nat Rev Neurosci, 2003. 4(5): p. 376-85.
73. Unkmeir, A., et al., Fibronectin mediates Opc-dependent internalization of Neisseria meningitidis in human brain microvascular endothelial cells. Mol Microbiol, 2002. 46(4): p. 933-46.
74. Thomas, D.D., et al., Treponema pallidum invades intercellular junctions of endothelial cell monolayers. Proc Natl Acad Sci U.S.A, 1988. 85(10): p. 3608-12.
75. Lee, J.H., et al., Receptors for Treponema pallidum attachment to the surface and matrix proteins of cultured human dermal microvascular endothelial cells. Yonsei Med J, 2003. 44(3): p. 371-8.
76. Cameron, C.E., Identification of a Treponema pallidum laminin-binding protein. Infect Immun, 2003. 71(5): p. 2525-33.
77. Fitzgerald, T.J., et al., Attachment of Treponema pallidum to fibronectin, laminin, collagen IV, and collagen I, and blockage of attachment by immune rabbit IgG. Br J Vener Dis, 1984. 60(6): p. 357-63.
78. Riley, B.S., et al., Virulent Treponema pallidum activates human vascular endothelial cells. J Infect Dis, 1992. 165(3): p. 484-93.
79. Lee, K.H., et al., Virulent Treponema pallidum 47 kDa antigen regulates the expression of cell adhesion molecules and binding of T-lymphocytes to cultured human dermal microvascular endothelial cells. Yonsei Med J, 2000. 41(5): p. 623-33.
80. Coleman, J.L., et al., Borrelia burgdorferi binds plasminogen, resulting in enhanced penetration of endothelial monolayers. Infect Immun, 1995. 63(7): p. 2478-84.
81. Coleman, J.L., et al., Plasminogen is required for efficient dissemination of B. burgdorferi in ticks and for enhancement of spirochetemia in mice. Cell, 1997. 89(7): p. 1111-9.
82. Coleman, J.L., J.A. Gebbia, and J.L. Benach, Borrelia burgdorferi and other bacterial products induce expression and release of the urokinase receptor (CD87). J Immunol, 2001. 166(1): p. 473-80.
83. Coleman, J.L. and J.L. Benach, The urokinase receptor can be induced by Borrelia burgdorferi through receptors of the innate immune system. Infect Immun, 2003. 71(10): p. 5556-64.
84. Coleman, J.L. and J.L. Benach, The generation of enzymatically active plasmin on the surface of spirochetes. Methods, 2000. 21(2): p. 133-41.
85. Gebbia, J.A., J.L. Coleman, and J.L. Benach, Borrelia spirochetes upregulate release and activation of matrix metalloproteinase gelatinase B (MMP-9) and collagenase 1 (MMP-1) in human cells. Infect Immun, 2001. 69(1): p. 456-62.
86. Lahteenmaki, K., P. Kuusela, and T.K. Korhonen, Bacterial plasminogen activators and receptors. FEMS Microbiol Rev, 2001. 25(5): p. 531-52.
87. Brissette, C.A., et al., Borrelia burgdorferi infection-associated surface proteins ErpP, ErpA, and ErpC bind human plasminogen. Infect Immun, 2009. 77(1): p. 300-6.
88. Sethi, N., et al., Interaction of a neurotropic strain of Borrelia turicatae with the cerebral microcirculation system. Infect Immun, 2006. 74(11): p. 6408-18.
89. Comstock, L.E., et al., A monoclonal antibody to OspA inhibits association of Borrelia burgdorferi with human endothelial cells. Infect Immun, 1993. 61(2): p. 423-31.
90. Rambukkana, A., et al., Neural targeting of Mycobacterium leprae mediated by the G domain of the laminin-alpha2 chain. Cell, 1997. 88(6): p. 811-21.
91. Leong, J.M., et al., Different classes of proteoglycans contribute to the attachment of Borrelia burgdorferi to cultured endothelial and brain cells. Infect Immun, 1998. 66(3): p. 994-9.
92. Coburn, J., J.M. Leong, and J.K. Erban, Integrin alpha IIb beta 3 mediates binding of the Lyme disease agent Borrelia burgdorferi to human platelets. Proc Natl Acad Sci U S A, 1993. 90(15): p. 7059-63.
93. Ebnet, K., et al., Borrelia burgdorferi activates nuclear factor-kappa B and is a potent inducer of chemokine and adhesion molecule gene expression in endothelial cells and fibroblasts. J Immunol, 1997. 158(7): p. 3285-92.
94. Coburn, J., et al., Integrins alpha(v)beta3 and alpha5beta1 mediate attachment of lyme disease spirochetes to human cells. Infect Immun, 1998. 66(5): p. 1946-52.
95. Virji, M., Microbial utilization of human signalling molecules. Microbiology, 1996. 142 (Pt 12): p. 3319-36.
96. Monroy, V., et al., Binding and activation of human plasminogen by Mycobacterium tuberculosis. Infect Immun, 2000. 68(7): p. 4327-30.
97. Badger, J.L., M.F. Stins, and K.S. Kim, Citrobacter freundii invades and replicates in human brain microvascular endothelial cells. Infect Immun, 1999. 67(8): p. 4208-15.
98. Cabanes, D., et al., Gp96 is a receptor for a novel Listeria monocytogenes virulence factor, Vip, a surface protein. EMBO J, 2005. 24(15): p. 2827-38.
99. Wyrick, P.B., Intracellular survival by Chlamydia. Cell Microbiol, 2000. 2(4): p. 275-82.
100. Opitz, B., et al., Nod1-mediated endothelial cell activation by Chlamydophila pneumoniae. Circ Res, 2005. 96(3): p. 319-26.
101. Inatsuka, C.S., S.M. Julio, and P.A. Cotter, Bordetella filamentous hemagglutinin plays a critical role in immunomodulation, suggesting a mechanism for host specificity. Proc Natl Acad Sci U.S.A., 2005. 102(51): p. 18578-83.
102. Berge, A. and U. Sjobring, PAM, a novel plasminogen-binding protein from Streptococcus pyogenes. J Biol Chem, 1993. 268(34): p. 25417-24.
103. Lu, R., et al., Affinity purification and partial characterization of the zonulin/zonula occludens toxin (Zot) receptor from human brain. J Neurochem, 2000. 74(1): p. 320-6.
104. Mun-Bryce, S. and G.A. Rosenberg, Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. Am J Physiol, 1998. 274(5 Pt 2): p. R1203-11.
105. Chakrabarti, A., Epidemiology of central nervous system mycoses. Neurol India, 2007. 55(3): p. 191-7.
106. Perfect, J.R. and A. Casadevall, Cryptococcosis. Infect Dis Clin North Am, 2002. 16(4): p. 837-74, v-vi.
107. Chretien, F., et al., Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia. J Infect Dis, 2002. 186(4): p. 522-30.
108. Jong, A., et al., Invasion of Cryptococcus neoformans into human brain microvascular endothelial cells requires protein kinase C-alpha activation. Cell Microbiol, 2008. 10(9): p. 1854-65.
109. Shea, J.M., et al., The cryptococcal enzyme inositol phosphosphingolipid-phospholipase C confers resistance to the antifungal effects of macrophages and promotes fungal dissemination to the central nervous system. Infect Immun, 2006. 74(10): p. 5977-88.
110. Olszewski, M.A., et al., Urease expression by Cryptococcus neoformans promotes microvascular sequestration, thereby enhancing central nervous system invasion. Am J Pathol, 2004. 164(5): p. 1761-71.
111. Fu, Y., et al., Expression of the Candida albicans gene ALS1 in Saccharomyces cerevisiae induces adherence to endothelial and epithelial cells. Infect Immun, 1998. 66(4): p. 1783-6.
112. Sundstrom, P., Adhesins in Candida albicans. Curr Opin Microbiol, 1999. 2(4): p. 353-7.
113. Huang, S.H. and A.Y. Jong, Cellular mechanisms of microbial proteins contributing to invasion of the blood-brain barrier. Cell Microbiol, 2001. 3(5): p. 277-87.
114. Jong, A.Y., et al., Binding of Candida albicans enolase to plasmin(ogen) results in enhanced invasion of human brain microvascular endothelial cells. J Med Microbiol, 2003. 52(Pt 8): p. 615-22.
115. Klotz, S.A. and R.L. Smith, A fibronectin receptor on Candida albicans mediates adherence of the fungus to extracellular matrix. J Infect Dis, 1991. 163(3): p. 604-10.
116. Forsyth, C.B., E.F. Plow, and L. Zhang, Interaction of the fungal pathogen Candida albicans with integrin CD11b/CD18: recognition by the I domain is modulated by the lectin-like domain and the CD18 subunit. J Immunol, 1998. 161(11): p. 6198-205.
117. Spreghini, E., et al., Evidence for alphavbeta3 and alphavbeta5 integrin-like vitronectin (VN) receptors in Candida albicans and their involvement in yeast cell adhesion to VN. J Infect Dis, 1999. 180(1): p. 156-66.
118. Aravalli, R.N., et al., Histoplasma capsulatum yeast phase-specific protein Yps3p induces Toll-like receptor 2 signaling. J Neuroinflammation, 2008. 5: p. 30.
119. MacPherson, G.G., et al., Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am J Pathol, 1985. 119(3): p. 385-401.
120. Silamut, K., et al., A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain. Am J Pathol, 1999. 155(2): p. 395-410.
121. Biswas, A.K., et al., Plasmodium falciparum uses gC1qR/HABP1/p32 as a receptor to bind to vascular endothelium and for platelet-mediated clumping. PLoS Pathog, 2007. 3(9): p. 1271-80.
122. Tripathi, A.K., D.J. Sullivan, and M.F. Stins, Plasmodium falciparum-infected erythrocytes decrease the integrity of human blood-brain barrier endothelial cell monolayers. J Infect Dis, 2007. 195(7): p. 942-50.
123. Cooke, B.M., et al., Rolling and stationary cytoadhesion of red blood cells parasitized by Plasmodium falciparum: separate roles for ICAM-1, CD36 and thrombospondin. Br J Haematol, 1994. 87(1): p. 162-70.
124. Sherman, I.W., S. Eda, and E. Winograd, Cytoadherence and sequestration in Plasmodium falciparum: defining the ties that bind. Microbes Infect, 2003. 5(10): p. 897-909.
125. Gray, C. and A. Craig, Fibrinogen binding to intercellular adhesion molecule 1: implications for Plasmodium falciparum adhesion. Infect Immun, 2002. 70(7): p. 3962-4.
126. Siau, A., et al., Whole-transcriptome analysis of Plasmodium falciparum field isolates: identification of new pathogenicity factors. J Infect Dis, 2007. 196(11): p. 1603-12.
127. Grab, D.J. and P.G. Kennedy, Traversal of human and animal trypanosomes across the blood-brain barrier. J Neurovirol, 2008. 14(5): p. 344-51.
128. Masocha, W., M.E. Rottenberg, and K. Kristensson, Migration of African trypanosomes across the blood-brain barrier. Physiol Behav, 2007. 92(1-2): p. 110-4.
129. Stiles, J.K., et al., Trypanosome apoptotic factor mediates apoptosis in human brain vascular endothelial cells. Mol Biochem Parasitol, 2004. 133(2): p. 229-40.
130. Alsam, S., et al., Acanthamoeba interactions with human brain microvascular endothelial cells. Microb Pathog, 2003. 35(6): p. 235-41.
131. Khan, N.A., Acanthamoeba and the blood-brain barrier: the breakthrough. J Med Microbiol, 2008. 57(Pt 9): p. 1051-7.
132. Schmiel, D.H. and V.L. Miller, Bacterial phospholipases and pathogenesis. Microbes Infect, 1999. 1(13): p. 1103-12.
133. Dieter, P., et al., Lipopolysaccharide-induced release of arachidonic acid and prostaglandins in liver macrophages: regulation by Group IV cytosolic phospholipase A2, but not by Group V and Group IIA secretory phospholipase A2. Cell Signal, 2002. 14(3): p. 199-204.
134. Harris, S.G., et al., Prostaglandins as modulators of immunity. Trends Immunol, 2002. 23(3): p. 144-50.
135. Khan, N.A. and R. Siddiqui, Acanthamoeba affects the integrity of human brain microvascular endothelial cells and degrades the tight junction proteins. Int J Parasitol, 2009. 39(14): p. 1611-6.
136. Kong, H.H., T.H. Kim, and D.I. Chung, Purification and characterization of a secretory serine proteinase of Acanthamoeba healyi isolated from GAE. J Parasitol, 2000. 86(1): p. 12-7.
137. Sissons, J., et al., Identification and properties of proteases from an Acanthamoeba isolate capable of producing granulomatous encephalitis. BMC Microbiol, 2006. 6: p. 42.
138. Alsam, S., et al., Extracellular proteases of Acanthamoeba castellanii (encephalitis isolate belonging to T1 genotype) contribute to increased permeability in an in vitro model of the human blood-brain barrier. J Infect, 2005. 51(2): p. 150-6.
139. Daubener, W., et al., Restriction of Toxoplasma gondii growth in human brain microvascular endothelial cells by activation of indoleamine 2,3-dioxygenase. Infect Immun, 2001. 69(10): p. 6527-31.
140. Gay-Andrieu, F., et al., Flow cytometric quantification of Toxoplasma gondii cellular infection and replication. J Parasitol, 1999. 85(3): p. 545-9.
141. Chadwick, D.R., Viral meningitis. Br Med Bull, 2005. 75-76: p. 1-14.
142. Gillet, J.P., P. Derer, and H. Tsiang, Axonal transport of rabies virus in the central nervous system of the rat. J Neuropathol Exp Neurol, 1986. 45(6): p. 619-34.
143. Gendelman, H.E., et al., Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia. J Infect Dis, 1998. 178(4): p. 1000-7.
144. Cavrois, M., J. Neidleman, and W.C. Greene, The achilles heel of the trojan horse model of HIV-1 trans-infection. PLoS Pathog, 2008. 4(6): p. e1000051.
145. Andras, I.E., et al., HIV-1 Tat protein alters tight junction protein expression and distribution in cultured brain endothelial cells. J Neurosci Res, 2003. 74(2): p. 255-65.
146. Kim, T.G. and W.H. Langridge, Synthesis of an HIV-1 Tat transduction domain-rotavirus enterotoxin fusion protein in transgenic potato. Plant Cell Rep, 2004. 22(6): p. 382-7.
147. Glass, W.G., et al., Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection. J Exp Med, 2005. 202(8): p. 1087-98.
148. Sitati, E., et al., CD40-CD40 ligand interactions promote trafficking of CD8+ T cells into the brain and protection against West Nile virus encephalitis. J Virol, 2007. 81(18): p. 9801-11.
149. Verma, S., et al., In vitro effects of selenium deficiency on West Nile virus replication and cytopathogenicity. Virol J, 2008. 5: p. 66.
150. Ruzek, D., et al., Breakdown of the Blood-Brain Barrier during Tick-Borne Encephalitis in Mice Is Not Dependent on CD8 T-Cells. PLoS One. 6(5): p. e20472.
151. Reiss, Y., et al., T cell interaction with ICAM-1-deficient endothelium in vitro: essential role for ICAM-1 and ICAM-2 in transendothelial migration of T cells. Eur J Immunol, 1998. 28(10): p. 3086-99.
152. Durieu-Trautmann, O., et al., Intercellular adhesion molecule 1 activation induces tyrosine phosphorylation of the cytoskeleton-associated protein cortactin in brain microvessel endothelial cells. J Biol Chem, 1994. 269(17): p. 12536-40.
153. Etienne, S., et al., ICAM-1 signaling pathways associated with Rho activation in microvascular brain endothelial cells. J Immunol, 1998. 161(10): p. 5755-61.
154. Miralles, F., et al., Actin dynamics control SRF activity by regulation of its coactivator MAL. Cell, 2003. 113(3): p. 329-42.
155. Cernuda-Morollon, E. and A.J. Ridley, Rho GTPases and leukocyte adhesion receptor expression and function in endothelial cells. Circ Res, 2006. 98(6): p. 757-67.
156. Alcaide, P., et al., p120-Catenin regulates leukocyte transmigration through an effect on VE-cadherin phosphorylation. Blood, 2008. 112(7): p. 2770-9.
157. Kehry, M.R., CD40-mediated signaling in B cells. Balancing cell survival, growth, and death. J Immunol, 1996. 156(7): p. 2345-8.
158. Schonbeck, U. and P. Libby, The CD40/CD154receptor/ligand dyad. Cell Mol Life Sci, 2001. 58(1): p. 4-43.
159. Greenwood, J., et al., Review: leucocyte-endothelial cell crosstalk at the blood-brain barrier: a prerequisite for successful immune cell entry to the brain. Neuropathol Appl Neurobiol. 37(1): p. 24-39.
160. van Wetering, S., et al., VCAM-1-mediated Rac signaling controls endothelial cell-cell contacts and leukocyte transmigration. Am J Physiol Cell Physiol, 2003. 285(2): p. C343-52.
161. Summersgill, J.T., et al., Interactions of Chlamydia pneumoniae with human endothelial cells. J Infect Dis, 2000. 181 Suppl 3: p. S479-82.
162. Newman, D.K., C. Hamilton, and P.J. Newman, Inhibition of antigen-receptor signaling by Platelet Endothelial Cell Adhesion Molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck). Blood, 2001. 97(8): p. 2351-7.
163. Newman, P.J. and D.K. Newman, Signal transduction pathways mediated by PECAM-1: new roles for an old molecule in platelet and vascular cell biology. Arterioscler Thromb Vasc Biol, 2003. 23(6): p. 953-64.
164. Couty, J.P., et al., PECAM-1 engagement counteracts ICAM-1-induced signaling in brain vascular endothelial cells. J Neurochem, 2007. 103(2): p. 793-801.
165. van Kempen, L.C., et al., Molecular basis for the homophilic activated leukocyte cell adhesion molecule (ALCAM)-ALCAM interaction. J Biol Chem, 2001. 276(28): p. 25783-90.
166. Alvarez, J.I., R. Cayrol, and A. Prat, Disruption of central nervous system barriers in multiple sclerosis. Biochim Biophys Acta. 1812(2): p. 252-64.
167. Mayer, M., Biochemical and biological aspects of the plasminogen activation system. Clin Biochem, 1990. 23(3): p. 197-211.
168. Pancholi, V., P. Fontan, and H. Jin, Plasminogen-mediated group A streptococcal adherence to and pericellular invasion of human pharyngeal cells. Microb Pathog, 2003. 35(6): p. 293-303.
169. Lahteenmaki, K., et al., Bacterial plasminogen receptors: in vitro evidence for a role in degradation of the mammalian extracellular matrix. Infect Immun, 1995. 63(9): p. 3659-64.
170. Lottenberg, R., C.C. Broder, and M.D. Boyle, Identification of a specific receptor for plasmin on a group A streptococcus. Infect Immun, 1987. 55(8): p. 1914-8.
171. Aung, H., et al., Bioactivation of latent transforming growth factor beta1 by Mycobacterium tuberculosis in human mononuclear phagocytes. Scand J Immunol, 2005. 61(6): p. 558-65.
172. Hu, L.T., et al., Binding of human plasminogen to Borrelia burgdorferi. Infect Immun, 1995. 63(9): p. 3491-6.
173. Xolalpa, W., et al., Identification of novel bacterial plasminogen-binding proteins in the human pathogen Mycobacterium tuberculosis. Proteomics, 2007. 7(18): p. 3332-41.
174. Lahteenmaki, K., S. Edelman, and T.K. Korhonen, Bacterial metastasis: the host plasminogen system in bacterial invasion. Trends Microbiol, 2005. 13(2): p. 79-85.
175. Sanderson-Smith, M.L., et al., The plasminogen-binding group A streptococcal M protein-related protein Prp binds plasminogen via arginine and histidine residues. J Bacteriol, 2007. 189(4): p. 1435-40.
176. Kieseier, B.C., et al., Differential expression of matrix metalloproteinases in bacterial meningitis. Brain, 1999. 122 (Pt 8): p. 1579-87.
177. Choi, D.H., et al., A novel intracellular role of matrix metalloproteinase-3 during apoptosis of dopaminergic cells. J Neurochem, 2008. 106(1): p. 405-15.
178. Kawasaki, Y., et al., Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med, 2008. 14(3): p. 331-6.
179. Serrati, S., et al., Systemic sclerosis fibroblasts inhibit in vitro angiogenesis by MMP-12-dependent cleavage of the endothelial cell urokinase receptor. J Pathol, 2006. 210(2): p. 240-8.
180. Parks, W.C., C.L. Wilson, and Y.S. Lopez-Boado, Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol, 2004. 4(8): p. 617-29.
181. Boire, A., et al., PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells. Cell, 2005. 120(3): p. 303-13.
182. Hummel, V., et al., Production of MMPs in human cerebral endothelial cells and their role in shedding adhesion molecules. J Neuropathol Exp Neurol, 2001. 60(4): p. 320-7.
183. Mandal, M., et al., Clinical implications of matrix metalloproteinases. Mol Cell Biochem, 2003. 252(1-2): p. 305-29.
184. Rosenberg, G.A., Matrix metalloproteinases in neuroinflammation. Glia, 2002. 39(3): p. 279-91.
185. Afonso, P.V., et al., Human blood-brain barrier disruption by retroviral-infected lymphocytes: role of myosin light chain kinase in endothelial tight-junction disorganization. J Immunol, 2007. 179(4): p. 2576-83.
186. Luabeya, M.K., et al., Blood-brain barrier disruption in simian immunodeficiency virus encephalitis. Neuropathol Appl Neurobiol, 2000. 26(5): p. 454-62.
187. Chong, Y.H., J.Y. Seoh, and H.K. Park, Increased activity of matrix metalloproteinase-2 in human glial and neuronal cell lines treated with HIV-1 gp41 peptides. J Mol Neurosci, 1998. 10(2): p. 129-41.
188. Arjona, A., et al., Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion. J Clin Invest, 2007. 117(10): p. 3059-66.
189. Wang, P., et al., Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain. J Virol, 2008. 82(18): p. 8978-85.
190. Wang, T., et al., Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med, 2004. 10(12): p. 1366-73.
191. Verma, S., et al., Reversal of West Nile virus-induced blood-brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor. Virology. 397(1): p. 130-8.
192. Leppert, D., et al., Matrix metalloproteinase (MMP)-8 and MMP-9 in cerebrospinal fluid during bacterial meningitis: association with blood-brain barrier damage and neurological sequelae. Clin Infect Dis, 2000. 31(1): p. 80-4.
193. Gaibani, P., et al., Major surface protein complex of Treponema denticola induces the production of tumor necrosis factor alpha, interleukin-1 beta, interleukin-6 and matrix metalloproteinase 9 by primary human peripheral blood monocytes. J Periodontal Res. 45(3): p. 361-6.
194. Oggioni, M.R., et al., Pneumococcal zinc metalloproteinase ZmpC cleaves human matrix metalloproteinase 9 and is a virulence factor in experimental pneumonia. Mol Microbiol, 2003. 49(3): p. 795-805.
195. Jobin, M.C., M. Gottschalk, and D. Grenier, Upregulation of prostaglandin E2 and matrix metalloproteinase 9 production by human macrophage-like cells: synergistic effect of capsular material and cell wall from Streptococcus suis. Microb Pathog, 2006. 40(1): p. 29-34.
196. Shin, J., S. Ji, and Y. Choi, Ability of oral bacteria to induce tissue-destructive molecules from human neutrophils. Oral Dis, 2008. 14(4): p. 327-34.
197. Schubert-Unkmeir, A., et al., Neisseria meningitidis induces brain microvascular endothelial cell detachment from the matrix and cleavage of occludin: a role for MMP-8. PLoS Pathog. 6(4): p. e1000874.
198. Azeh, I., et al., Experimental pneumococcal meningitis in rabbits: the increase of matrix metalloproteinase-9 in cerebrospinal fluid correlates with leucocyte invasion. Neurosci Lett, 1998. 256(3): p. 127-30.
199. Harris, J.E., et al., Monocytes infected with Mycobacterium tuberculosis regulate MAP kinase-dependent astrocyte MMP-9 secretion. J Leukoc Biol, 2007. 81(2): p. 548-56.
200. Asahi, M., et al., Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci, 2001. 21(19): p. 7724-32.
201. Grab, D.J., et al., Anaplasma phagocytophilum-Borrelia burgdorferi coinfection enhances chemokine, cytokine, and matrix metalloprotease expression by human brain microvascular endothelial cells. Clin Vaccine Immunol, 2007. 14(11): p. 1420-4.
202. Kolb, S.A., et al., Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid. J Neuroimmunol, 1998. 84(2): p. 143-50.
203. Hu, L.T., et al., Isolation, cloning, and expression of a 70-kilodalton plasminogen binding protein of Borrelia burgdorferi. Infect Immun, 1997. 65(12): p. 4989-95.
204. Rupprecht, T.A., et al., Adhesion of Borrelia garinii to neuronal cells is mediated by the interaction of OspA with proteoglycans. J Neuroimmunol, 2006. 175(1-2): p. 5-11.
205. Bohse, M.L. and J.P. Woods, Surface localization of the Yps3p protein of Histoplasma capsulatum. Eukaryot Cell, 2005. 4(4): p. 685-93.
206. Mendu, D.R., et al., Protein folding intermediates of invasin protein IbeA from Escherichia coli. FEBS J, 2008. 275(3): p. 458-69.
207. Huang, S.H., et al., Identification and characterization of an Escherichia coli invasion gene locus, ibeB, required for penetration of brain microvascular endothelial cells. Infect Immun, 1999. 67(5): p. 2103-9.
208. Will, W.R. and L.S. Frost, Hfq is a regulator of F-plasmid TraJ and TraM synthesis in Escherichia coli. J Bacteriol, 2006. 188(1): p. 124-31.
209. Lecuit, M. and P. Cossart, Genetically-modified-animal models for human infections: the Listeria paradigm. Trends Mol Med, 2002. 8(11): p. 537-42.
210. Pron, B., et al., Interaction of Neisseria maningitidis with the components of the blood-brain barrier correlates with an increased expression of PilC. J Infect Dis, 1997. 176(5): p. 1285-92.
211. Nassif, X., Interaction mechanisms of encapsulated meningococci with eucaryotic cells: what does this tell us about the crossing of the blood-brain barrier by Neisseria meningitidis? Curr Opin Microbiol, 1999. 2(1): p. 71-7.
212. Fischer, H.G., et al., Host cells of Toxoplasma gondii encystation in infected primary culture from mouse brain. Parasitol Res, 1997. 83(7): p. 637-41.